Results 221 to 230 of about 5,245,251 (341)

Seeking for the boundaries of de-escalation in antiplatelet therapy for acute coronary syndrome. [PDF]

Eur Heart J Cardiovasc Pharmacother
Galli M, Gragnano F, Valgimigli M.
europepmc   +1 more source

ALOX15 mediates thrombin‐induced myristoylation, trafficking, and interaction of protease‐activated receptors, leading to platelet activation and hemostasis

The FEBS Journal, EarlyView.
The role of PARs in platelet function is fairly known; however, the underlying mechanisms are not fully understood. We report that thrombin myristoylates PAR4 in mouse platelets and PAR1 and PAR4 in human platelets, facilitating their membrane transport and interaction, leading to PAR3/4 heterodimers in mice and PAR1/4 heterodimers in humans.
Suresh Govatati, Chandra Sekhar Yadavalli, Md Monirul Hoque, Swapna Thota, Gadiparthi N. Rao   +4 more
wiley   +1 more source

Witnessing a possible revolution in antiplatelet therapy for coronary artery bypass grafting. [PDF]

Eur Heart J Cardiovasc Pharmacother
Galli M, Gragnano F, Gaudino M.
europepmc   +1 more source

Antiplatelet therapy.

Nihon Naika Gakkai Zasshi, 1994
openaire   +2 more sources

Proteolytic remodelling of the extracellular matrix by pericytes

The FEBS Journal, EarlyView.
Pericytes are specialised perivascular cells intimately connected with endothelial cells and essential for the maintenance of vascular beds. They contribute to the formation and remodelling of the extracellular matrix by actively secreting proteases and protease inhibitors.
Tina Burkhard, Ella Milne, Kate Qian, Paola Campagnolo, Salvatore Santamaria   +4 more
wiley   +1 more source

Rare Bleeding Disorders and Bleeding Disorder of Unknown Cause: Current Understanding and Recent Developments

Haemophilia, EarlyView.
ABSTRACT Rare bleeding disorders (RBDs) represent a diverse group of inherited conditions involving coagulation factors or platelets. These conditions, such as Glanzmann thrombasthenia (GT) or severe coagulation factor deficiencies, are uncommon. In contrast, bleeding disorder of unknown cause (BDUC) is a diagnosis of exclusion without an identifiable ...
Alessandro Casini, Robert Klamroth, Bauke Haisma, Dino Mehic, Saskia E. M. Schols   +4 more
wiley   +1 more source

Prophylactic tirofiban versus oral dual antiplatelet therapy in patients undergoing endovascular treatment of intracranial aneurysms: A meta-analysis. [PDF]

Medicine (Baltimore)
Miao Y, Li Q, Chen J, Liu Z.
europepmc   +1 more source

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.

Journal of the American Medical Association (JAMA), 2016
R. Yeh, E. Secemsky, D. Kereiakes, Sharon-Lise T Normand, A. Gershlick, David J Cohen, J. Spertus, P. Steg, D. Cutlip, M. Rinaldi, E. Camenzind, W. Wijns, Patricia Apruzzese, Yang Song, J. Massaro, L. Mauri   +15 more
semanticscholar   +1 more source

The Impact of Periodontal Health Interventions on the Risk of Ischemic Stroke: A Systematic Review and Meta‐Analysis

International Journal of Dental Hygiene, EarlyView.
ABSTRACT Aim To systematically review the evidence on the relationship between periodontal health interventions and the risk of first‐ever ischemic stroke. Materials and Methods Search strategy included electronic and hand searching to January 2025. MEDLINE (OVID), EMBASE (OVID), SCOPUS, LILACS, Web of Science (WOS) and Cochrane Central Register of ...
Jorge Moldes, Joao Botelho, Manuel Rodríguez‐Yáñez, Vanessa Machado, Juan Blanco, Tomás Sobrino, Rogelio Leira, Yago Leira   +7 more
wiley   +1 more source

A Multicenter Propensity Score-Matched Cohort Study of Preoperative Antiplatelet Therapy and Postoperative Outcomes in Elderly Surgical Patients. [PDF]

Medicina (Kaunas)
Song S, Seo H, Kim IS, Kim M, Hee LY, Kim JE, Choi SI, Kim DH, Lee YH, Park M, Choi JB, Lee C, Yoo SH, Yu HK, Noh C, Choi SY, Kwak SG.   +16 more
europepmc   +1 more source